We estimate that the CEO of ADC Therapeutics SA ($ADCT), Ameet Mallik, received a compensation of $2,453,150 in 2025. This is an increase of 25.09% from an estimated $1,837,628 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on April 20, 2026. Note that parsing errors may occur.
You can track $ADCT on Quiver Quantitative's $ADCT stock dashboard.
$ADCT Stock Insider Trading Activity
$ADCT Stock insiders have traded $ADCT stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $ADCT stock by insiders over the last 6 months:
- GROUP, LLC REDMILE has made 0 purchases and 6 sales selling 5,880,415 shares for an estimated $19,636,340.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ADCT Stock Hedge Fund Activity
We have seen 62 institutional investors add shares of $ADCT Stock stock to their portfolio, and 43 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TCG CROSSOVER MANAGEMENT, LLC added 10,000,000 shares (+719.3%) to their portfolio in Q4 2025, for an estimated $35,300,000
- EVENTIDE ASSET MANAGEMENT, LLC added 3,364,067 shares (+inf%) to their portfolio in Q4 2025, for an estimated $11,875,156
- NANTAHALA CAPITAL MANAGEMENT, LLC added 3,209,144 shares (+141.6%) to their portfolio in Q4 2025, for an estimated $11,328,278
- POINT72 ASSET MANAGEMENT, L.P. removed 3,121,034 shares (-38.4%) from their portfolio in Q4 2025, for an estimated $11,017,250
- LYNX1 CAPITAL MANAGEMENT LP removed 1,325,848 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $4,680,243
- PROSIGHT MANAGEMENT, LP added 1,005,035 shares (+13.5%) to their portfolio in Q4 2025, for an estimated $3,547,773
- BLACKROCK, INC. added 915,610 shares (+20.3%) to their portfolio in Q4 2025, for an estimated $3,232,103
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
